BridgeBio

BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.

Domain

bridgebio.com

Employees

501-1000

Last Funding

$550.0M

Founded

2014

Frequently Asked Questions

What technologies does BridgeBio use?+

BridgeBio uses 10 technologies including Google Tag Manager, OneTrust, Optimizely.

What industry is BridgeBio in?+

BridgeBio operates in the Biotechnology industry.

Where is BridgeBio based?+

BridgeBio is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026